Meet BacVax: a PBC startup working on a vaccine to prevent ear infections in young children.
Dr. Terrence Stull’s company, called BacVax, is developing a vaccine to prevent ear infections in young children.
BacVax is a University of Arizona spinoff founded by Stull, former senior vice president of research at Phoenix Children’s Hospital.
BacVax uses molecular genetics to study Haemophilus influenzae, a common cause of ear infections. Stull moved his startup from the University of Arizona College of Medicine – Phoenix to 850 PBC on the Phoenix Bioscience Core in July 2021, noting the building is a prime location to grow and expand.
Related reading:
Check out the new Connect Labs at 850 PBC, opening in just a few short weeks.
Check out the video below and read more about BacVax here on the Arizona PBS website as part of its Health Tomorrow segment, supported by the Phoenix Bioscience Core.
More news from the PBC
- TEDx UArizona – How immunotherapy could help us beat cancer
- CommonSpirit Health Appoints Anthony Houston President of its Arizona Market
- TGen study reveals genetic drivers of common liver disease
- UArizona Health Sciences Tucson & Phoenix experts team up: Normalizing opioid use disorder treatments to improve care
- Arizona bioscience growth continues, sets record highs
- City of Hope appoints Aleksandar Sekulic to key cancer genomics role at TGen
- Arizona BioIndustry Association opens office on Phoenix Bioscience Core at Connect Labs